401 related articles for article (PubMed ID: 27317091)
41. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.
Petralia G; Koh DM; Attariwala R; Busch JJ; Eeles R; Karow D; Lo GG; Messiou C; Sala E; Vargas HA; Zugni F; Padhani AR
Radiology; 2021 Jun; 299(3):494-507. PubMed ID: 33904776
[TBL] [Abstract][Full Text] [Related]
42. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer.
Arita Y; Yoshida S; Waseda Y; Takahara T; Ishii C; Ueda R; Kwee TC; Miyahira K; Ishii R; Okuda S; Jinzaki M; Fujii Y
Eur J Radiol; 2021 Apr; 137():109581. PubMed ID: 33578087
[TBL] [Abstract][Full Text] [Related]
44. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
45. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
46. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
47. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
[TBL] [Abstract][Full Text] [Related]
48. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer.
Yoshida S; Takahara T; Ishii C; Arita Y; Waseda Y; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Fujii Y
Clin Genitourin Cancer; 2020 Aug; 18(4):e391-e396. PubMed ID: 31902713
[TBL] [Abstract][Full Text] [Related]
49. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
50. Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
Kumasaka S; Motegi S; Kumasaka Y; Nishikata T; Otomo M; Tsushima Y
Br J Radiol; 2022 Mar; 95(1131):20210459. PubMed ID: 34111963
[TBL] [Abstract][Full Text] [Related]
51. A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer.
De Visschere PJL; Standaert C; Fütterer JJ; Villeirs GM; Panebianco V; Walz J; Maurer T; Hadaschik BA; Lecouvet FE; Giannarini G; Fanti S
Eur Urol Oncol; 2019 Feb; 2(1):47-76. PubMed ID: 30929846
[TBL] [Abstract][Full Text] [Related]
52. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
53.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
54. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
55. Application of whole-body MRI to detect the recurrence of lung cancer.
Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
[TBL] [Abstract][Full Text] [Related]
56. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer.
Barnes A; Alonzi R; Blackledge M; Charles-Edwards G; Collins DJ; Cook G; Coutts G; Goh V; Graves M; Kelly C; Koh DM; McCallum H; Miquel ME; O'Connor J; Padhani A; Pearson R; Priest A; Rockall A; Stirling J; Taylor S; Tunariu N; van der Meulen J; Walls D; Winfield J; Punwani S
Br J Radiol; 2018 Jan; 91(1081):20170577. PubMed ID: 29076749
[TBL] [Abstract][Full Text] [Related]
57. Comparison of
Van Damme J; Tombal B; Collette L; Van Nieuwenhove S; Pasoglou V; Gérard T; Jamar F; Lhommel R; Lecouvet FE
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771449
[TBL] [Abstract][Full Text] [Related]
58. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
[TBL] [Abstract][Full Text] [Related]
59. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
60. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
